Crossing the blood-brain barrier is critical to increasing therapeutic windows for viable therapies. Organ- and cell-specific delivery is exactly what Praesidia’s platform does, unlocking the best possible standard of care.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Arlington, Ma 02476, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.praesidiabio.com
- Keywords
- Biotherapeutics, Drug Discovery, Blood Brain Barrier Penetration, Linker Enzyme Substrate System (LESS), ProDrug, Targeted Therapy, Neuro-Oncology, Oncology, Central Nervous System (CNS), Neurodegenerative Diseases, Blood Brain Barrier (BBB), Computational Modeling, Dose-Limiting Toxicity, ncreasing Maximum Tolerable Dose (MTD), Maximizing Therapeutic Index, Medicine, Chemistry, Manufacturing and Controls (CMC), Oral Formulation, Biologics, Biotechnology.
- HQ
- Arlington, MA
Praesidia Biotherapeutics Questions
Praesidia Biotherapeutics's website is https://www.praesidiabio.com
Praesidia Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/praesidia-bio
Praesidia Biotherapeutics has
8 employees.
View email and phone details for 8
employees at Praesidia Biotherapeutics.
Praesidia Biotherapeutics's industry is
Biotechnology Research
Praesidia Biotherapeutics's top competitors are
Distill.io,
Life Science Cares Philadelphia,
Context Therapeutics,
Allele Capital,
Theertha Biopharma,
Radius Health, Inc.,
Credence Genomics (Pte) Ltd,
Testeasy Genomic Lab,
Novelgene Technologies Private Limited,
Peptris Technologies.
Praesidia Biotherapeutics's categories are Biotechnology Research
Praesidia Biotherapeutics's founding year is 2021
